ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.191,24
1,10%
S&P 500
5.127,79
0,00%
Dow Jones
38.675,68
0,00%
Euro vs US Dollar
1,07835
0,24%
Bitcoin
63.793,94
-0,32%
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Fate Therapeutics Inc (FATE)

  7. Fate Therapeutics Inc (FATE) News

FATE Fate Therapeutics Inc

4,08
0,02 (0,49%)
Vor Marktöffnung
Zuletzt aktualisiert: 14:05:49
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Fate Therapeutics Inc FATE NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
Upgrade Icon
0,02 0,49% 4,08 14:05:49
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
4,06
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
06.5.202414:00GLOBEFate Therapeutics to Webcast Conference Call Reporting First..
03.5.202422:30GLOBEFate Therapeutics Announces Presentation of FT522..
22.4.202422:30GLOBEFate Therapeutics Announces Presentation of FT819..
03.4.202414:00GLOBEFate Therapeutics to Present at 23rd Annual Needham Virtual..
02.4.202422:01GLOBEFate Therapeutics Reports New Employee Inducement Award..
19.3.202413:44GLOBEFate Therapeutics Announces Pricing of $100 Million..
05.3.202422:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.3.202422:01GLOBEFate Therapeutics Reports New Employee Inducement Award..
04.3.202419:29EDGAR2Form 144 - Report of proposed sale of securities
01.3.202414:00GLOBEFate Therapeutics to Present at Upcoming March Investor..
26.2.202422:10EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
26.2.202422:03EDGAR2Form 8-K - Current report
26.2.202422:01GLOBEFate Therapeutics Reports Fourth Quarter and Full Year 2023..
15.2.202414:00GLOBEFate Therapeutics to Webcast Conference Call Reporting..
13.2.202400:06EDGAR2Form SC 13G - Statement of acquisition of beneficial..
02.2.202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.2.202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.2.202422:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.2.202422:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.2.202422:01GLOBEFate Therapeutics Reports New Employee Inducement Awards..
30.1.202422:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29.1.202419:44EDGAR2Form 144 - Report of proposed sale of securities
25.1.202422:19EDGAR2Form SC 13G - Statement of acquisition of beneficial..
10.1.202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10.1.202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10.1.202422:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10.1.202422:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09.1.202422:39EDGAR2Form 144 - Report of proposed sale of securities
09.1.202422:36EDGAR2Form 144 - Report of proposed sale of securities
09.1.202422:36EDGAR2Form 144 - Report of proposed sale of securities
09.1.202422:35EDGAR2Form 144 - Report of proposed sale of securities
08.1.202414:00GLOBEFate Therapeutics Announces Initiation of Phase 1 Clinical..
03.1.202422:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.1.202418:17EDGAR2Form 144 - Report of proposed sale of securities
19.12.202322:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18.12.202317:40EDGAR2Form 144 - Report of proposed sale of securities
13.12.202323:00GLOBEFate Therapeutics Reports New Employee Inducement Grants..
28.11.202306:15EDGAR2Form EFFECT - Notice of Effectiveness
13.11.202322:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09.11.202317:57EDGAR2Form 144 - Report of proposed sale of securities
08.11.202323:10EDGAR2Form 8-K - Current report
08.11.202322:44EDGAR2Form S-3 - Registration statement under Securities Act of..
08.11.202322:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08.11.202322:03EDGAR2Form 8-K - Current report
08.11.202322:01GLOBEFate Therapeutics Reports Third Quarter 2023 Financial..
25.10.202314:00GLOBEFate Therapeutics to Webcast Conference Call Reporting Third..
01.9.202323:29EDGAR2Form 8-K - Current report
31.8.202314:00GLOBEFate Therapeutics to Present at Upcoming September Investor..
21.8.202322:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18.8.202321:58EDGAR2Form 144 - Report of proposed sale of securities

Kürzlich von Ihnen besucht

NASDAQ
FATE
Fate Therapeutics
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten